The invention object of the Patent concerns the formulation of a gel for oral administration containing water-soluble drugs as active compounds and a gelling agent to replace commercial tablets and to allow the adherence of the drug in dysphagia patients
This formulation is innovative and capable of ensuring a drug release comparable to that of the original solid dosage forms, obtained simply by dispersing the tablet and / or capsule in the medium used to disperse the thickening polymer.
An advantage of this formulation is represented by the preparative method that allows to disperse the pharmaceutical forms available on the market such as tablets, coated and uncoated, or the contents of capsules or immediate-release sachets, directly into the solvent that will then be used for the preparation of the polymeric dispersion, avoiding any handling operation by the operator and eliminating the dangers related to loss of active ingredient, contamination and dosing errors.
In this way, the active ingredient, which was originally available only in solid or liquid form unsuitable for administration in dysphagic patients, is found in a dosage form of consistency suitable for swallowing even in the dysphagic patient without its release kinetics being altered, remaining as effective as in its original form.